Patient-reported outcomes of severe facial erythema of rosacea

• Research type

  Research Study

• Full title

  Patient-reported outcomes of Brimonidine Tartrate 0.5% gel for treatment of severe facial erythema of rosacea

• IRAS ID

  128632

• Contact name

  Anthony BEWLEY

• Contact email

  anthony.bewley@bartshealth.nhs.uk

• Sponsor organisation

  Galderma R&D

• Eudract number

  2012-005686-12

• REC name

  Scotland A REC

• REC reference

  13/SS/0072

• Date of REC Opinion

  13 May 2013

• REC opinion

  Further Information Favourable Opinion